Short Interest in MediPharm Labs Corp. (OTCMKTS:MEDIF) Declines By 15.9%

MediPharm Labs Corp. (OTCMKTS:MEDIF) was the target of a significant decline in short interest in December. As of December 31st, there was short interest totalling 597,100 shares, a decline of 15.9% from the December 15th total of 710,100 shares. Based on an average daily volume of 412,200 shares, the days-to-cover ratio is currently 1.4 days.

MediPharm Labs Trading Down 6.9 %

MEDIF traded down $0.00 during midday trading on Thursday, hitting $0.05. The company had a trading volume of 143,196 shares, compared to its average volume of 96,780. The stock’s 50 day moving average price is $0.05 and its 200 day moving average price is $0.05. MediPharm Labs has a 52 week low of $0.04 and a 52 week high of $0.07.

MediPharm Labs Company Profile

MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products.